People: Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

63.00EUR
15 Aug 2014
Price Change (% chg)

€-1.90 (-2.93%)
Prev Close
€64.90
Open
€65.10
Day's High
€65.10
Day's Low
€62.95
Volume
964,425
Avg. Vol
511,931
52-wk High
€69.07
52-wk Low
€55.53

Search Stocks

Krebs, Rolf 

Brief Biography

Prof. Dr. Rolf Krebs has been Chairman of the Supervisory Board at Merck KGaA since July 1, 2009. He has been Member of the Supervisory Board at Merck KGaA since July 1, 2006. He is retired Physician. He graduated from Johannes Gutenberg-Universitat Mainz with a Doctorate of Science degree in Medicine. He is Chairman of the Supervisory Board of Epigenomics AG and Ganymed Pharmaceuticals AG. He is Member of the Supervisory Board of Merz GmbH & Co. KGaA, Senator GmbH &Co KGaA and Merz Pharmaceuticals GmbH. He is on the Board of Partners at E. Merck KG and on the Board of Air Liquide S.A. He was Chairman of the Research and Development Committee, and is as Member of the Personnel Committee and Nomination Committee at the Company.

Basic Compensation

Total Annual Compensation, EUR Long-Term Incentive Plans, EUR All Other, EUR Fiscal Year Total, EUR
95,026 -- -- 95,026

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Rolf Krebs

95,026

Karl-Ludwig Kley

7,311,000

Heiner Wilhelm

72,019

Marcus Kuhnert

--

Kai Beckmann

4,951,000

Constantin Fest

--
As Of 30 Dec 2013
Search Stocks